Investing

HCW Biologics : HCWB

HCWB

Stock Data

$1.63

$0.05 (2.98%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

HCW Biologics Inc is an innovative biotechnology company dedicated to developing cutting-edge immunotherapies and vaccine technologies for pressing health challenges such as cancer and infectious diseases. Leveraging proprietary platforms that harness the power of the immune system, HCW aims to deliver transformative biopharmaceutical solutions through its robust pipeline of clinical candidates. With strategic collaborations and a strong commitment to addressing unmet medical needs, HCW Biologics is poised for significant advancements in patient care, marking it as a compelling investment opportunity in the expanding biotechnology sector.

All HCW Biologics Articles

2 Articles

Alex Sirois | May 18, 2026 at 10:35 AM EDT

Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners

President Trump’s 12-word remark, “I don’t think about Americans’ financial situation, I don’t think about anybody,” hit the wires, and…